Skip to main content
Stephen Greene, MD, Cardiology, Durham, NC

Stephen John Greene MD

Adult Congenital Heart Disease, Heart Failure & Transplantation


Physician

Join to view full profile
  • 2301 Erwin Rd # Dumc3845Durham, NC 27705

  • Phone+1 919-684-8111

Dr. Greene is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Cardiovascular Disease, 2015 - 2017
  • Northwestern University The Feinberg School of Medicine
    Northwestern University The Feinberg School of MedicineClass of 2012

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2015 - 2027
  • IL State Medical License
    IL State Medical License 2012 - 2015
  • Advanced Heart Failure and Transplant Cardiology
    American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • [Board 512] Longitudinal Changes in Medication Dosing Among Patients With Heart Failure With Reduced Ejection Fraction: From the CHAMP-HF Registry
    Stephen Greene, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/16/2019

Press Mentions

  • AHA Heart Failure Registry Making a Major Impact After 20 Years
    AHA Heart Failure Registry Making a Major Impact After 20 YearsJuly 30th, 2026
  • Reduced Mortality May Offset Hyperkalemia Risk with Optimal RAS Inhibitor, MRA Therapy for Heart Failure
    Reduced Mortality May Offset Hyperkalemia Risk with Optimal RAS Inhibitor, MRA Therapy for Heart FailureOctober 3rd, 2025
  • Study Finds Shortening Vericiguat Ramp up to Target Dose in HFrEF from Two to One Steps Is Safe
    Study Finds Shortening Vericiguat Ramp up to Target Dose in HFrEF from Two to One Steps Is SafeJune 12th, 2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: